- $2.22bn
- $5.69bn
- $1.68bn
- 96
- 86
- 59
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,168 | 1,325 | 1,606 | 1,706 | 1,678 |
Cost of Revenue | |||||
Gross Profit | 779 | 907 | 1,150 | 1,235 | 1,237 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 858 | 856 | 1,116 | 1,167 | 1,151 |
Operating Profit | 310 | 469 | 490 | 539 | 527 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 234 | 379 | 337 | 375 | 411 |
Provision for Income Taxes | |||||
Net Income After Taxes | 179 | 303 | 291 | 249 | 322 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 179 | 304 | 292 | 234 | 267 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 179 | 304 | 297 | 240 | 274 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 33.4 | 40.9 | 44.5 | 37.9 | 47 |
Dividends per Share |